Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Indian J Tuberc ; 67(3): 448-451, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-723447

ABSTRACT

A group of senior doctors with vast clinical experience met on 19th July'20 under the aegis of Academy of Advanced Medical Education. The panel looked at Ivermectin, one of the old molecule and evaluated it's use in COVID 19 (Novel Coronavirus Disease 2019) management. After critical panel discussion, all the attending doctors came to a conclusion that Ivermectin can be a potential molecule for prophylaxis and treatment of people infected with Coronavirus, owing to its anti-viral properties coupled with effective cost, availability and good tolerability and safety.


Subject(s)
Betacoronavirus , Coronavirus Infections/drug therapy , Ivermectin/therapeutic use , Pneumonia, Viral/drug therapy , Antiparasitic Agents/therapeutic use , COVID-19 , Humans , Pandemics , Risk Factors , SARS-CoV-2 , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL